Mason has answered your question; I'm just repeating in different words.
FTO levels don't change.
What changes is the activity of that FTO as measured by changes in methylation of m6A.
This m6A methylation effect can and will be measured during the bisantrene lead-in dose before the other drug starts to be administered.
Speculative M&A Transaction Analysis, page-724
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
0.000(0.00%) |
Mkt cap ! $276.9M | |||
| Open | High | Low | Value | Volume |
| $1.64 | $1.64 | $1.62 | $56.91K | 35.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4461 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 4075 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |